Skip to content

← All news

Markets

Climb Bio reports phase 1 data for IgA nephropathy drug

1 source ·1 article ·Sep 3, 11:10 UTC Climb Bio

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 3, 11:10 UTC

Climb Bio reports phase 1 data for IgA nephropathy drug